Clinical characteristics of pyogenic liver abscess with and without biliary surgery history: a retrospective single-center experience.
Biliary surgery
Bilioenteric anastomoses
Pyogenic liver abscess
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
10 May 2024
10 May 2024
Historique:
received:
09
01
2024
accepted:
03
05
2024
medline:
11
5
2024
pubmed:
11
5
2024
entrez:
10
5
2024
Statut:
epublish
Résumé
Pyogenic liver abscess (PLA) is a common hepatobiliary infection that has been shown to have an increasing incidence, with biliary surgery being identified as a trigger. Our aim was to investigate the clinical characteristics and treatments of PLA patients with and without a history of biliary surgery (BS). The study included a total of 353 patients with PLA who received treatment at our hospital between January 2014 and February 2023. These patients were categorized into two groups: the BS group (n = 91) and the non-BS group (n = 262). In the BS group, according to the anastomosis method, they were further divided into bilioenteric anastomoses group (BEA, n = 22) and non-bilioenteric anastomoses group (non-BEA, n = 69). Clinical characteristics were recorded and analyzed. The percentage of PLA patients with BS history was 25.78%. The BS group exhibited elevated levels of TBIL and activated APTT abnormalities (P = 0.009 and P = 0.041, respectively). Within the BS group, the BEA subgroup had a higher prevalence of diabetes mellitus (P < 0.001) and solitary abscesses (P = 0.008) compared to the non-BEA subgroup. Escherichia coli was more frequently detected in the BS group, as evidenced by positive pus cultures (P = 0.021). The BS group exhibited reduced treatment efficacy compared to those non-BS history (P = 0.020). Intriguingly, the BS group received a higher proportion of conservative treatment (45.05% vs. 21.76%), along with reduced utilization of surgical drainage (6.59% vs. 16.41%). Patients with BS history, especially those who have undergone BEA, have an increased susceptibility to PLA formation without affecting prognosis.
Sections du résumé
BACKGROUND & AIMS
OBJECTIVE
Pyogenic liver abscess (PLA) is a common hepatobiliary infection that has been shown to have an increasing incidence, with biliary surgery being identified as a trigger. Our aim was to investigate the clinical characteristics and treatments of PLA patients with and without a history of biliary surgery (BS).
METHODS
METHODS
The study included a total of 353 patients with PLA who received treatment at our hospital between January 2014 and February 2023. These patients were categorized into two groups: the BS group (n = 91) and the non-BS group (n = 262). In the BS group, according to the anastomosis method, they were further divided into bilioenteric anastomoses group (BEA, n = 22) and non-bilioenteric anastomoses group (non-BEA, n = 69). Clinical characteristics were recorded and analyzed.
RESULTS
RESULTS
The percentage of PLA patients with BS history was 25.78%. The BS group exhibited elevated levels of TBIL and activated APTT abnormalities (P = 0.009 and P = 0.041, respectively). Within the BS group, the BEA subgroup had a higher prevalence of diabetes mellitus (P < 0.001) and solitary abscesses (P = 0.008) compared to the non-BEA subgroup. Escherichia coli was more frequently detected in the BS group, as evidenced by positive pus cultures (P = 0.021). The BS group exhibited reduced treatment efficacy compared to those non-BS history (P = 0.020). Intriguingly, the BS group received a higher proportion of conservative treatment (45.05% vs. 21.76%), along with reduced utilization of surgical drainage (6.59% vs. 16.41%).
CONCLUSIONS
CONCLUSIONS
Patients with BS history, especially those who have undergone BEA, have an increased susceptibility to PLA formation without affecting prognosis.
Identifiants
pubmed: 38730338
doi: 10.1186/s12879-024-09378-x
pii: 10.1186/s12879-024-09378-x
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
479Subventions
Organisme : National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
ID : 82200686
Organisme : Shaanxi Provincial People's Hospital Incubation Project
ID : 2022YJY-14
Informations de copyright
© 2024. The Author(s).
Références
Rahimian J, Wilson T, Oram V, Holzman RS. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis. 2004;39(11):1654–1659.
Shi SH, Xia WL, Guo HJ, Kong HS, Zheng SS. Unique characteristics of pyogenic liver abscesses of biliary origin. Surgery. 2016;159:1316–24.
doi: 10.1016/j.surg.2015.11.012
pubmed: 26775071
Serste T, Bourgeois N, Eynden FV, Coppens E, Deviere J, Le Moine O. Endoscopic drainage of pyogenic liver abscesses with suspected biliary origin. Am J Gastroenterol. 2007;102:1209–15.
doi: 10.1111/j.1572-0241.2007.01140.x
pubmed: 17378905
Montvuagnard T, Thomson V, Durieux M, et al. Superinfection of focal liver lesions after bile duct procedures. Diagn Interv Imaging. 2012;93(3):e191–5.
Hoffmann R, Rempp H, Schmidt D, Pereira PL, Claussen CD, Clasen S. Prolonged antibiotic prophylaxis in patients with bilioenteric anastomosis undergoing percutaneous radiofrequency ablation. J Vasc Interv Radiol. 2012;23:545–51.
doi: 10.1016/j.jvir.2011.12.025
pubmed: 22365593
Czerwonko ME, Huespe P, Elizondo CM, et al. Risk factors and outcomes of pyogenic liver abscess in adult liver recipients: a matched case-control study. HPB (Oxford). 2018;20:583–90.
doi: 10.1016/j.hpb.2017.12.005
pubmed: 29496466
Czerwonko ME, Huespe P, Bertone S, et al. Pyogenic liver abscess: current status and predictive factors for recurrence and mortality of first episodes. HPB (Oxford). 2016;18:1023–30.
doi: 10.1016/j.hpb.2016.09.001
pubmed: 27712972
Ruiz-Hernandez JJ, Leon-Mazorra M, Conde-Martel A, Marchena-Gomez J, Hemmersbach-Miller M, Betancor-Leon P. Pyogenic liver abscesses: mortality-related factors. Eur J Gastroenterol Hepatol. 2007;19:853–8.
doi: 10.1097/MEG.0b013e3282eeb53b
pubmed: 17873608
Bismuth H, Franco D, Corlette MB, Hepp J. Long term results of Roux-en-Y hepaticojejunostomy. Surg Gynecol Obstet. 1978;146(2):161–167.
Lam YH, Wong SKH, Lee DWH, et al. ERCP and pyogenic liver abscess. Gastrointest Endosc. 1999;50:340–4.
doi: 10.1053/ge.1999.v50.98065
pubmed: 10462653
Tachopoulou OA, Vogt DP, Henderson JM, Baker M, Keys TF. Hepatic abscess after liver transplantation: 1990–2000. Transplantation. 2003;75(1):79–83.
doi: 10.1097/00007890-200301150-00014
pubmed: 12544875
Tan SL, Yu XL, Liang P, et al. Preventing intrahepatic infection after ablation of liver tumours in biliary-enteric anastomosis patients. Int J Hyperthermia. 2017;33:664–9.
doi: 10.1080/02656736.2017.1292002
pubmed: 28540775
Röthlin MA, Löpfe M, Schlumpf R, Largiadèr F. Long-term results of hepaticojejunostomy for benign lesions of the bile ducts. Am J Surg. 1998;175:22–6.
doi: 10.1016/S0002-9610(97)00229-8
pubmed: 9445233
Stefanini P, Carboni M, Patrassi N, Basoli A, de Bernardinis G, Negro P. Roux-en-Y hepaticojejunostomy: a reappraisal of its indications and results. Ann Surg. 1975;181(2):213–219.
doi: 10.1097/00000658-197502000-00016
pubmed: 1089393
pmcid: 1343756
Tu JF, Huang XF, Hu RY, You HY, Zheng XF, Jiang FZ. Comparison of laparoscopic and open surgery for pyogenic liver abscess with biliary pathology. World J Gastroenterol. 2011;17:4339–43.
doi: 10.3748/wjg.v17.i38.4339
pubmed: 22090791
pmcid: 3214710
Lin YX, Du ZQ, Wu RQ. Posters. Hepatology. 2020;72:131A–1159A.
Sugawara T, Shindoh J, Nishioka Y, Hashimoto M. Total bilirubin amount in drainage fluid can be an early predictor for severe biliary fistula after hepatobiliary surgery. Biosci Trends. 2017;11:588–94.
doi: 10.5582/bst.2017.01208
pubmed: 29070759
Choi HY, Cheon GJ, Kim YD, Han KH, Kim KS, Nah BK. Comparison of clinical characteristics between cryptogenic and biliary pyogenic liver abscess. Korean J Gastroenterol. 2007;49:238–44.
pubmed: 17464169
Thng CB, Tan YP, Shelat VG. Gas-forming pyogenic liver abscess: a world review. Ann Hepatobiliary Pancreat Surg. 2018;22:11–8.
doi: 10.14701/ahbps.2018.22.1.11
pubmed: 29536051
pmcid: 5845606
Lederman ER, Crum NF. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol. 2005;100(2):322–331.
Matthews JB, Gertsch P, Baer HU, Blumgart LH. Hepatic abscess after biliary tract procedures. Surg Gynecol Obstet. 1990;170(6):469–475.
Sugiyama M, Atomi Y. Pyogenic hepatic abscess with biliary communication. Am J Surg. 2002;183:205–8.
doi: 10.1016/S0002-9610(01)00869-8
pubmed: 11918890
Carrel T, Lerut J, Baer H, Blumgart LH. Hepatic abscess following biliary tract surgery. Etiology, treatment and results. Eur J Surg. 1991;157(3):209–213.
Yaylak F, Canbaz H, Caglikulekci M, et al. Liver tissue inducible nitric oxide synthase (iNOS) expression and lipid peroxidation in experimental hepatic ischemia reperfusion injury stimulated with lipopolysaccharide: the role of aminoguanidine. J Surg Res. 2008;148:214–23.
doi: 10.1016/j.jss.2007.10.008
pubmed: 18222473
Tazawa J, Sakai Y, Maekawa S, et al. Solitary and multiple pyogenic liver abscesses: characteristics of the patients and efficacy of percutaneous drainage. Am J Gastroenterol. 1997;92(2):271–274.